Albert Stroucken Net Worth

The estimated Net Worth of Albert P L Stroucken is at least $10.2 Milione dollars as of 20 March 2023. Mr. Stroucken owns over 3,930 units of Baxter International stock worth over $1,600,842 and over the last 21 years he sold BAX stock worth over $8,228,027. In addition, he makes $338,976 as Independent Director at Baxter International.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Stroucken BAX stock SEC Form 4 insiders trading

Albert has made over 47 trades of the Baxter International stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 3,930 units of BAX stock worth $145,135 on 20 March 2023.

The largest trade he's ever made was exercising 384,615 units of Baxter International stock on 29 February 2016 worth over $3,896,150. On average, Albert trades about 16,351 units every 88 days since 2004. As of 20 March 2023 he still owns at least 40,765 units of Baxter International stock.

You can see the complete history of Mr. Stroucken stock trades at the bottom of the page.

Albert Stroucken biography

Albert P.L. Stroucken is Independent Director of the Company. Mr. Stroucken served as Executive Chairman of the Board of Owens-Illinois, a glass packaging company, from January 1 to June 30, 2016, having served as Chairman, President and Chief Executive Officer from 2006 through 2015. From 1998 to 2006, Mr. Stroucken served as President and Chief Executive Officer of H.B. Fuller Company, a manufacturer of adhesives, sealants, coatings, paints and other specialty chemicals. Mr. Stroucken served as Chairman of H.B. Fuller Company from 1999 to 2006. From 1997 to 1998, he was General Manager of the Inorganics Division of Bayer AG. From 1992 to 1997, Mr. Stroucken was Executive Vice President and President of the Industrial Chemicals Division of Bayer Corporation. Mr. Stroucken previously served as a director of Baxalta and as a director of Shire until its acquisition by Takeda Pharmaceutical Company Ltd. in January 2019.

What is the salary of Albert Stroucken?

As the Independent Director of Baxter International, the total compensation of Albert Stroucken at Baxter International is $338,976. There are 12 executives at Baxter International getting paid more, with Jose Almeida having the highest compensation of $13,913,800.

How old is Albert Stroucken?

Albert Stroucken is 72, he's been the Independent Director of Baxter International since 2004. There are 2 older and 26 younger executives at Baxter International. The oldest executive at Baxter International Inc. is James Gavin, 74, who is the Independent Director.

What's Albert Stroucken's mailing address?

Albert's mailing address filed with the SEC is ONE BAXTER PARKWAY, , DEERFIELD, IL, 60015.

Insiders trading at Baxter International

Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney e Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.

What does Baxter International do?

baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

Complete history of Mr. Stroucken stock trades at Baxter International, H.B. Fuller e O-I Glass Inc

Baxter International executives and stock owners

Baxter International executives and other stock owners filed with the SEC include:

• Jose Almeida,
  Chairman of the Board, President, Chief Executive Officer
• James Saccaro,
  Chief Financial Officer, Executive Vice President
• Jeanne Mason,
  Senior Vice President - Human Resources
• Giuseppe Accogli,
  Senior Vice President, President- America
• Sean Martin,
  Senior Vice President, General Counsel
• Cristiano Franzi,
  Senior Vice President and President, EMEA
• Jose E. Almeida,
  Chairman, Pres & CEO
• Cristiano Franzi,
  Sr. VP & Pres for EMEA
• Giuseppe Accogli,
  Exec. VP & COO
• James K. Saccaro,
  Exec. VP & CFO
• Sean B. W. Martin,
  Sr. VP & Gen. Counsel
• Thomas Stallkamp,
  Lead Independent Director
• Albert Stroucken,
  Independent Director
• Peter Hellman,
  Independent Director
• James Gavin,
  Independent Director
• Patricia Morrison,
  Independent Director
• Stephen Oesterle,
  Independent Director
• Amy Wendell,
  Independent Director
• John Forsyth,
  Independent Director
• Michael Mahoney,
  Independent Director
• Cathy Smith,
  Independent Director
• Thomas Chen,
  Independent Director
• Jacqueline Kunzler,
  Senior Vice President and Chief Quality Officer
• Andrew Frye,
  Senior Vice President and President, APAC
• Brian Stevens,
  Senior Vice President, Chief Accounting Officer, Controller
• David S. Rosenbloom,
  Sr. VP & Gen. Counsel
• Clare Trachtman,
  VP of Investor Relations
• Brian C. Stevens,
  Sr. VP, Chief Accounting Officer & Controller
• Wilber C. Boren IV,
  Pres of Advanced Surgery
• Andrew Frye,
  Sr. VP & Pres of APAC
• Jeanne K. Mason,
  Sr. VP of HR
• Stacey Eisen,
  Sr. VP of Global Communications
• Talvis P. Love,
  Sr. VP & Chief Information Officer
• David P. Scharf,
  Corporate Vice President
• Kees J Storm,
  Director
• Marcus Schabacker,
  CVP, Chief Scientific Officer
• Robert Felicelli,
  CVP, Quality
• Brik V Eyre,
  CVP, Hospital Products
• Carole J Uhrich,
  Director
• Paul Vibert,
  CVP, International
• Scott Pleau,
  CVP - Operations
• Caroline Karp,
  CVP, Controller
• Point Llc Loeb Daniel S Third,
  
• Christopher A. Toth,
  EVP,Group Pres, Kidney Care
• William A. Ii Ampofo,
  Director
• Steven Flynn,
  SVP, President, APAC
• Peter M Wilver,
  Director
• David Brent Shafer,
  Director
• Thomas J Jr Sabatino,
  Senior Vice President
• Yuan Chia Pei,
  Director
• Cheryl L White,
  Corporate Vice President
• Joy A Amundson,
  Corporate Vice President
• Jill M Schaaf,
  CVP, Renal
• Harry M Jansen Jr Kraemer,
  Chairman and
• Robert J. Hombach,
  Corporate Vice President & CFO
• James E Utts,
  Corporate Vice President
• Uma Chowdhry,
  Director
• Peter J Arduini,
  Corporate Vice President
• Bruce Mc Gillivray,
  Corporate Vice President
• Sebastian J Bufalino,
  Corporate Vice President
• Jean Luc Butel,
  Corporate Vice President
• James M Gatling,
  Corporate Vice President
• John C Moon,
  Corporate Vice President
• Salto Carlos Del,
  Senior Vice President
• Wayne T Hockmeyer,
  Director
• Joseph B Martin,
  Director
• Michael J Baughman,
  Corporate Vice President
• Steven J Meyer,
  Treasurer
• Michael J Tucker,
  Senior Vice President
• James R Hurley,
  Corporate Vice President
• Monroe E Trout,
  Director
• Thomas Fang Tyan Chen,
  Director
• Nevelle J Jeharajah,
  Corporate Vice President
• Robert M Davis,
  Corp. VP, CFO and Treasurer
• Jan Stern Reed,
  Corporate Secretary
• Thomas H Glanzmann,
  Senior Vice President
• Walter E Boomer,
  Director
• Gail D Fosler,
  Director
• Phillip L. Batchelor,
  Corporate Vice President
• Karenann K Terrell,
  Corporate Vice President
• Robert L Jr Parkinson,
  Chairman of the Board and
• Karen J May,
  Corporate Vice President
• Timothy P Lawrence,
  CVP, Operations
• Blake E Devitt,
  Director
• John J Greisch,
  Senior Vice President & CFO
• Munib Islam,
  Director
• Gregory P Young,
  Corporate Vice President
• Susan R Lichtenstein,
  Corporate Vice President,
• Lawrence T Gibbons,
  Corporate Vice President
• David F Drohan,
  Senior Vice President
• Fred L Turner,
  Director
• Norbert G Riedel,
  Corporate Vice President
• Brian P Anderson,
  Senior Vice President
• Ludwig Hantson,
  Corporate Vice President
• David S. Wilkes,
  Director
• Nancy M Schlichting,
  Director
• Joel T. Grade,
  EVP and CFO
• Alok Sonig,
  EVP,Group President, Pharma
• David S. Rosenbloom,
  EVP and General Counsel
• Heather Knight,
  EVP,Group Pres,Med Products
• Reazur Rasul,
  EVP,Group Pres, Healthcare
• Jeffrey A Craig,
  Director
• Stephen H Rusckowski,
  Director
• James W Borzi,
  EVP,Chief Supply Chain Officer